Better known as the light sensor that sets the body’s biological clock, melanopsin also plays an important role in vision: Via its messengers-so-called melanopsin-expressing retinal ganglion cells, or mRGCs-it forwards information about the brightness …
Anti-VEGF, Trabeculectomy With Mitomycin C Could Help Treat Neovascular Glaucoma
More than 80% of patients with neovascular glaucoma who were treated with intravitreal bevacizumab and panretinal photocoagulation achieved complete regression of iris neovascularization, and mean IOP was significantly reduced after trabeculectomy with…
Anti-VEGF, Trabeculectomy With Mitomycin C Could Help Treat Neovascular Glaucoma
More than 80% of patients with neovascular glaucoma who were treated with intravitreal bevacizumab and panretinal photocoagulation achieved complete regression of iris neovascularization, and mean IOP was significantly reduced after trabeculectomy with…
Avastin/Lucentis Update 44: United Kingdom Closer to Allowing Avastin for AMD
While the U.S. comes closer to showing the equivalency of Avastin to Lucentis for treating the wet form of age-related macular degeneration, when the CATT Study (Comparisons of Age-Related Macular Degeneration Treatments Trials) results become public, …
NICE’s Report On The Feasibility Of Appraising The Use Of Bevacizumab (Avastin) To Treat Eye Conditions
NICE has published its findings after exploring the feasibility of advising the NHS on the clinical and cost effectiveness of bevacizumab (Avastin, Genentech/Roche) to treat wet age-related macular degeneration (AMD), the leading cause of blindness in …
Vision community, FDA discuss use of PROs to improve labeling of ophthalmic treatments, products
The vision community is discussing with the Food and Drug Administration how vision-related patient-reported outcomes might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, poli…